Scientific Program - IDS 2024

Get to know our Speakers

Until 20 February 2024

Welcome to the 8th International Diabetes Summit

Dear Colleagues,

Diabetes is increasing in epidemic proportions worldwide. In India alone, more than 74 million people have Diabetes. The need of the hour is to empower Health Care providers with Basic and Advanced Diabetes Care expertise for better management of Diabetes and its associated complications.

The Chellaram Diabetes Institute (CDI), well known for its commitment towards the fight against Diabetes, has been organizing Annual International Diabetes Summits (IDS) since 2017 with huge success.

We are now conducting our 8th International Diabetes Summit from 15th March to 17th March 2024 in Pune.

The 8th International Diabetes Summit 2024 is part of CDI’s efforts to tackle the escalating problem of Diabetes in our midst. With the best-in-class Speakers from the leading global Diabetes Institutions – accompanied by accomplished Indian experts – this conference would help bring the latest and the best practices in Diabetes care to Clinicians treating people with Diabetes.

World-renowned scientific experts in the field of Diabetes including Clinicians and Researchers from Karolinska Institutet – Sweden, Mayo Clinic – USA, Keele University – UK, Stellenbosch University – South Africa, National University of Singapore – Singapore, Imperial College – UK, University of Leicester, UK and many more have agreed to grace the occasion. Indian experts will also participate and bring out our country’s perspective in managing Diabetes.

We invite you to participate in this conference, which will have a never-before charm as far as Diabetes Conferences in this part of the world are concerned.

Dr. A G Unnikrishnan
Conference Chairperson

DATE

March 15 – 17, 2024

(Friday to Sunday)

VENUE

JW Marriott, Pune

 

Meet our Conference Speakers

Dr. Kamlesh Khunti

UK

Dr. Pankaj Shah

USA

Dr. Andrew JM Boulton

UK

Dr. C.B.Sanjeevi

Sweden

Online Registration

Register early and get a discount

National Delegate / HCPs#

#Health care provider Non MBBS/ Para Medics/Researcher

INR 14,000/person

Symposium on Diabetes in Pregnancy And Women's Health

International Delegate

USD 500/person

PG Student*

*Includes PHFI / CDI Course Participants

INR 9,000/person
(Certificate from HOD is mandatory)
Closed

Scientific Highlights – IDS 2024

  • New therapies for diabetic kidney disease
  • Glucose management in stroke
  • Insulin – GLP1 hybrids in primary care
  • SMBG in the CGM era
  • Will newer peptides change global obesity?
  • Sarcopenic obesity in daily diabetology
  • Activin – tirzepatide for fat-selective weight loss
  • Clinical importance of recognizing lipedema
  • Is the C-peptide test coming back?
  • Triple antibody test for better diagnostics
  • GLP1- RA vs gliptin-gliflozin: a comparison
  • Shorter acting insulins: fast, faster, fastest
  • The underuse of ezetimibe and bempedoic acid
  • All about PCSK9i therapy
  • Olpasiran therapy and Lipoprotein (a)
  • The enigma that is icosapent ethyl
  • Diet and the four horsemen
  • The truth about bulletproof coffee
  • When is protein intake too much?
  • Meal replacement: true or fake shakes?
  • Practical approach to diabetes in pregnancy
  • Diabetic “mycosis” is emerging
  • Body composition in diabetes practice
  • Saroglitazar, semaglutide and the fibroscan
  • Precision, fuzzy logic and the doctor’s brain
  • Glycemia and a fight for the cloud
  • Weekly insulins. Next, a monthly therapy?
  • Achieving dominion over glucagon action
  • MASLD: making the name more meaningful
  • Anatomy of a prescription
  • Will bariatric surgery face extinction?
  • Making diabetes-specific antibiotic prescription
  • Type 2 diabetes remission – is it sustainable?
  • CGM + MSI is better than CSII + SMBG
  • Ideal treatment of early gestational diabetes
  • Calories, carbs and the healthspan question
  • Setting up a diabetes research center
  • Managing Acute Charcot Foot
  • CGM in people without diabetes
  • Ketosis prone diabetes

Sponsors

Strategic Partners

In Association with

Official Digital Partner